Luminous Ventures

Investor type Micro VC
Founders Isabel Fox Lomax Ward

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 24
Rounds per year 7.75
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Exits 1
Key employees 4
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Artificial Intelligence
  • Information Technology
  • Health Care
  • Machine Learning
  • Biotechnology
Summary

Luminous Ventures is the famous VC, which was founded in 2015. The leading representative office of defined VC is situated in the London. The company was established in Europe in United Kingdom.

This organization was formed by Isabel Fox, Lomax Ward. We also calculated 4 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Luminous Ventures, startups are often financed by Entrepreneur First, UK Innovation & Science Seed Fund, SOSV. The meaningful sponsors for the fund in investment in the same round are IQ Capital, SOSV, Entrepreneur First. In the next rounds fund is usually obtained by SOSV, iNovia Capital, Talis Capital.

Among the most popular portfolio startups of the fund, we may highlight Sparrho, Beyond, BioBeats. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 1 or 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Hospital.

The common things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2018.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Luminous Ventures:
Typical Co-investors
Luminous Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Luminous Ventures:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AISprouts -
Canyon Angels Arizona, Phoenix, United States
Deep Fork Capital California, San Francisco, United States
Hajimari Japan, Tokyo
Ideable Venture Finland, Helsinki, Southern Finland
Lion Ventures California, San Francisco, United States
Magic Johnson Enterprises Beverly Hills, California, United States
Nautica New York, New York, United States
NueCura Partners, LLC Brentwood, Tennessee, United States
SLI International Venture Massachusetts, United States, Waltham

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ellipsis Health

Fitness
Health Care
Information Technology
Software
$26M15 Jun 2021 San Francisco, California, United States

Molecule.one

Artificial Intelligence
Pharmaceutical
Software
$4M01 Jun 2021 Warsaw, Mazowieckie, Poland

Treos Bio

Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Therapeutics
$16M31 Mar 2021 London, England, United Kingdom

LGN

Artificial Intelligence
Hardware
Information Technology
Sensor
$1M23 Mar 2021 London, England, United Kingdom

Cytoseek

Biotechnology
Life Science
Medical
Pharmaceutical
$4M16 Mar 2021 Bristol, England, United Kingdom

Magdrive

$1M17 Dec 2020 United Kingdom, England

Biomage

Biotechnology
Data Visualization
Life Science
$850K08 Dec 2020 Glasgow, Scotland, United Kingdom

Ellipsis Health

Fitness
Health Care
Information Technology
Software
$6M01 Dec 2020 San Francisco, California, United States

Kernal Biologics

Biotechnology
Pharmaceutical
Therapeutics
06 Nov 2020 Cambridge, Massachusetts, United States
News
Ellipsis Health Raises $26M in Series A Funding

– Ellipsis Health is a San Francisco, CA-based developer of a voice vital sign to quantify and manage depression and anxiety at scale.
– The company raised $26m in Series A funding.
– The round was led by SJF Ventures with participation from AblePartners, Akhil Paul at Caparo Group, Alumni Ventures, Divesh Makan, Gaingels, Gary Loveman, Generator Ventures, Greycroft, Helmy Eltoukhy, Joanne Bradford, Khosla Ventures, Luminous Ventures, Marc Benioff’s TIME Ventures, Richard Socher, Ricardo Villela Marino, SpringTide Ventures, and What If Ventures.
– The company intends to use the funds to continue to grow its customer base, expand global partnerships, build a multidisciplinary team, research, and develop new voice-based technology, expand its voice vital sign to address the mental health of children and adolescents.

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round

– Polish computational chemistry outfit Molecule.one has raised $4.6m to expand its quest to bring theoretical drug molecules to reality.
– The funding round was led by Atmos Ventures, with a long list of participating investors: AME Cloud Ventures, Cherubic Ventures, Firlej Kastory, Inventures, Luminous Ventures, Sunfish Partners, and individuals including Bayer executive Sebastian Guth.
– The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it.
– After all, these molecules are brand new to science — no one has created them before, so why should anyone know?
– Molecule.one creates a workflow starting with ordinary off-the-shelf chemicals and provides step by step instructions using known methods of how to go from A to B… and to C, D and so on (it’s rarely simple).

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Luminous Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: